Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai

Blood (2022) 140 (Supplement 1): 12439.

https://doi.org/10.1182/blood-2022-157665

Published: 2022

Journal Articles

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Xi Wang, Feifei Che, Wanjun Cao, Zichen Ye, Hong Zheng, Xiaobing Huang, Rong Xiao, Wen Wang, Xuemei Ye, Lin He, Jingying Dai

Blood (2021) 138 (Supplement 1): 4702.

https://doi.org/10.1182/blood-2021-146768

Published: 2021

Journal Articles

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Yu Wang, Chuanyan Jiang, Xi Yang, Jingying Dai, PhD, Mengying Zou, Yijing Wang, Jun Wang, Jiafei Wu, Hui LI, MD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-139729

Published: 2020

Journal Articles

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Wangjun Cao, Lin He, Hong Zheng, MDPhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD, Jingying Dai, PhD

Blood (2020) 136 (Supplement 1): 53–54.

https://doi.org/10.1182/blood-2020-138462

Published: 2020

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

Chenglong Li, MDand PhD, Xi Yang, Jingying Dai, PhD, Ningning Tang, Hong Zheng, MD PhD, Chunsen Wang, MD, Xiaobing Huang

Blood (2019) 134 (Supplement_1): 1966.

https://doi.org/10.1182/blood-2019-126632

Published: 2019

Journal Articles

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Jingying Dai, PhD, Hong Zheng, MD PhD, Xiaobing Huang, Xi Yang, Xiaodong WANG, MD

Blood (2019) 134 (Supplement_1): 5376.

https://doi.org/10.1182/blood-2019-128413

Published: 2019

Journal Articles

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

Xi Yang, Hong Zheng, MD PhD, Jingying Dai, PhD, Chenglong Li, MDand PhD, Rong Zhang, MD PhD, Xiaodong WANG, MD, Chunsen Wang, MD, Xiaobing Huang

Blood (2018) 132 (Supplement 1): 3424.

https://doi.org/10.1182/blood-2018-99-111671

Published: 2018

Journal Articles

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

Jingying Dai, PhD, Xi Yang, Xiaobing Huang, Hong Zheng, MD PhD, Xiaodong Wang, MD

Blood (2018) 132 (Supplement 1): 4272.

https://doi.org/10.1182/blood-2018-99-113032

Published: 2018

Journal Articles

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Xi Yang, Xiaobing Huang, MDand PhD, Hong Zheng, MDPhD, Chenglong Li, MDand PhD, Jingying Dai, PhD, Rong Zhang, MDand PhD, Xiaodong Wang, PhD, Chunsen Wang, MD

Blood (2017) 130 (Supplement 1): 3278.

https://doi.org/10.1182/blood.V130.Suppl_1.3278.3278

Published: 2017

NARROW

Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

Pomalidomide Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells

This Is a Title: Cytarabine Combined with PD-1 Inhibitor in the Treatment of R/R-AML: A Report of 3 Cases and Literature Review

Dasatinib Promotes the Maturation of Healthy Donors and Chronic Myelogenous Leukemia Patients Derived Dendritic Cells

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Dose-Adjusted Granulocyte Colony-Stimulating Factor Plus Dexamethasone Achieves More CD34+ Cell Mobilization and Earlier Engraftment in Haploidentical Hematopoietic Stem Cell Transplantation

The Increase on Th1 and CD8+T Levels While a Decrease on Treg Level after Dasatinib Treatment Indicate a Better Therapeutic Response to Dasatinib and Deeper Clinical Remission in Chronic Myelogenous Leukemia Patients

Epigenetic Therapy Targets Th1/Th17 Polarization to Reversing Immune Evasion and Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation in Non-APL AML Patients

Dasatinib Significantly Enhances the Level of Th1 Cells While Decreases the Level of Treg Cells in Chronic Myeloid Leukemia Patients, and Th1 Can be a Potential Marker for Evaluating the Therapeutic Efficacy and Prognosis

This Is a Title in Chidamide, a Novel HDAC Inhibitor, Is Effective for Treating Leukemia Relapse Post Allogeneic Stem Cell Transplantation and Results in Th1 Polarization in AML Patients with AML1-ETO

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only